İrFan Orhan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
İrFan Orhan has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Karakeci
Department of Urology, Fırat University, Elazığ, Turkey
6 shared publications - Tunç Ozan
Firat University, School of Medicine
5 shared publications - Erdem Akbay
Department of Urology, Faculty of Medicine, Mersin University, Mersin, Turkey
3 shared publications - Ahmet Keles
Istanbul Medeniyet University
2 shared publications - Fatih Firdolas
Firat University Medical Faculty, Department for Urology, Elazig, Turkey
2 shared publications - Necip Pirincci
Department of Urology, Faculty of Medicine, Yuzuncu Yil University, Van, Turkey
2 shared publications
Latest Publications
- Open Access
- 17 February 2026
- Published by Springer Nature in BMC Urology
- Vol. 26 (1)
Comparative value of postoperative inflammatory indices in predicting recurrence in T3 stage renal cell carcinoma: superiority of the Cally index
This study evaluated the comparative efficacy of postoperative inflammatory indices (C-reactive protein–Albumin–Lymphocyte Index [Cally Index],
- 17 February 2026
- Published by Springer Nature in BMC Urology
- Vol. 26 (1)
Open AccessComparative value of postoperative inflammatory indices in predicting recurrence in T3 stage renal cell carcinoma: superiority of the Cally index
This study evaluated the comparative efficacy of postoperative inflammatory indices (C-reactive protein–Albumin–Lymphocyte Index [Cally Index],
- Open Access
- 29 August 2025
- Published by MediHealth Academy in Intercontinental Journal of Internal Medicine
- Vol. 3 (3) , 43-47
Can long-term treatment of Hashimoto's thyroiditis effectively improve sexual dysfunction in women
Aims: Numerous studies have identified thyroid diseases as a significant risk factor for women’s sexual health. This study aimed to evaluate how treatment of women diagnosed with Hashimoto’s thyroiditis affected their sexual function and psychological well-being, comparing them with a control group. Methods: In this study, 61 sexually active women with permanent primary hypothyroidism, diagnosed for at least one year and treated for at least 6 months between January 2022 and December 2023, were included. The inclusion criteria for group 1 were as follows: participants had to have overt hypothyroidism with a thyroid stimulating hormone level >10 IU/ml and a serum free T4 level <0.86 ng/dl. The control group comprised 31 sexually active, age-matched, healthy women. Results: Response to treatment was assessed using the Female Sexual Function Index questionnaire and the Beck Depression Inventory by interview. No significant difference was found between the two groups in terms of Female sexual function index parameters and Beck depression scores (p: 0.198 and p:0.353 respectively) except in TSH levels (p: 0.016). Conclusion: Long-term (at least 6 months) treatment of hypothyroidism may be able to improve sexual dysfunction in women. Further studies of larger series and longer treatment follow-up are needed to confirm the present findings.
- 29 August 2025
- Published by MediHealth Academy in Intercontinental Journal of Internal Medicine
- Vol. 3 (3) , 43-47
Open AccessCan long-term treatment of Hashimoto's thyroiditis effectively improve sexual dysfunction in women
Aims: Numerous studies have identified thyroid diseases as a significant risk factor for women’s sexual health. This study aimed to evaluate how treatment of women diagnosed with Hashimoto’s thyroiditis affected their sexual function and psychological well-being, comparing them with a control group. Methods: In this study, 61 sexually active women with permanent primary hypothyroidism, diagnosed for at least one year and treated for at least 6 months between January 2022 and December 2023, were included. The inclusion criteria for group 1 were as follows: participants had to have overt hypothyroidism with a thyroid stimulating hormone level >10 IU/ml and a serum free T4 level <0.86 ng/dl. The control group comprised 31 sexually active, age-matched, healthy women. Results: Response to treatment was assessed using the Female Sexual Function Index questionnaire and the Beck Depression Inventory by interview. No significant difference was found between the two groups in terms of Female sexual function index parameters and Beck depression scores (p: 0.198 and p:0.353 respectively) except in TSH levels (p: 0.016). Conclusion: Long-term (at least 6 months) treatment of hypothyroidism may be able to improve sexual dysfunction in women. Further studies of larger series and longer treatment follow-up are needed to confirm the present findings.
- Open Access
- 1 January 2024
- Published by Universidad del Zulia in Revista Científica de la Facultad de Ciencias Veterinarias
- Vol. XXXIV (1) , 1-7
Evaluating Adropine levels in kidney tissue after Methotrexate treatment in rats: a prospective experimental study
In this study, it was aimed to investigate Adropin levels in kidney tissues after Methotrexate (MTX) administration to identify potential changes following administration of agents with antioxidant/anti–inflammatory potential. Twenty four adult rats male albino Wistar rats were used in this study, and randomly divided into four groups. Control: These rats did not receive any treatment during the 14–day (d) experiment. N–acetylcysteine (NAC): These rats were administered 100 mg·kg-1·day-1 NAC intraperitoneally (i.p.) for 14 d. MTX: A single dose of 20 mg·kg-1 MTX was administered i.p. at the beginning of the study. MTX+ NAC: A single dose of 20 mg·kg-1 MTX was administered i.p. at the beginning of the study, and the rats were given 100 mg·kg-1·day-1 NAC i.p. for 14 d. Total antioxidant, and serum Adropin levels were found to be the lowest in the MTX group while the oxidant levels were significantly lower in the MTX group than in the MTX+NAC group (P<0.001). TUNEL positivity was similar among the groups, and no significant differences were observed. It was considered that these findings have shed light on the role of Adropin in the development of kidney failure following MTX administration.
- 1 January 2024
- Published by Universidad del Zulia in Revista Científica de la Facultad de Ciencias Veterinarias
- Vol. XXXIV (1) , 1-7
Open AccessEvaluating Adropine levels in kidney tissue after Methotrexate treatment in rats: a prospective experimental study
In this study, it was aimed to investigate Adropin levels in kidney tissues after Methotrexate (MTX) administration to identify potential changes following administration of agents with antioxidant/anti–inflammatory potential. Twenty four adult rats male albino Wistar rats were used in this study, and randomly divided into four groups. Control: These rats did not receive any treatment during the 14–day (d) experiment. N–acetylcysteine (NAC): These rats were administered 100 mg·kg-1·day-1 NAC intraperitoneally (i.p.) for 14 d. MTX: A single dose of 20 mg·kg-1 MTX was administered i.p. at the beginning of the study. MTX+ NAC: A single dose of 20 mg·kg-1 MTX was administered i.p. at the beginning of the study, and the rats were given 100 mg·kg-1·day-1 NAC i.p. for 14 d. Total antioxidant, and serum Adropin levels were found to be the lowest in the MTX group while the oxidant levels were significantly lower in the MTX group than in the MTX+NAC group (P<0.001). TUNEL positivity was similar among the groups, and no significant differences were observed. It was considered that these findings have shed light on the role of Adropin in the development of kidney failure following MTX administration.
- Open Access
- 26 November 2021
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 47 (6) , 501-508
Trends in benign prostatic hyperplasia surgery over the years: A multicenter 14-year retrospective study
Objective: The aim of this study is to show the surgical trend over the past 14 years using the data from five major centers in Turkey with accumulated experience in benign prostatic hyperplasia (BPH) surgery. Material and methods: This study included 94,954 patients with low urinary tract symptoms (LUTSs) secondary to BPH. By using electronic databases, we identified 7,163 patients who underwent BPH surgery, including monopolar transurethral prostate resection (M-TURP), bipolar transurethral prostate resection (BTURP), transurethral incision of the prostate (TUIP), open prostatectomy (OP), and holmium laser enucleation of the prostate (HoLEP) from 2006 to 2019. The years were grouped as 2006-2010, 2011-2015, and 2016-2019. Results: The total number of outpatient treatments for BPH increased by 72.9% from 5,379 in 2006 to 9,302 in 2019. Until 2019, the annual number of surgeries increased from 375 to 937 (increasing 150%). All surgical approaches for BPH, except TUIP, were most frequently performed between the ages of 60 and 69. The rate of surgery including M-TURP, B-TURP, and TUIP was statistically different between 2006 and 2010, 2011 and 2015, and 2016 and 2019 (P < .001), except OP (P ¼ .071). The highest increase was observed in HoLEP in the first half of the 2010s compared to the second half of the 2010s. The rate of M-TURP decreased from 77.9% to 17.9% from 2016 to 2019. Conclusion: With the aging population, the number of patients diagnosed and treated with BPH is increasing. B-TURP as a resection technique and HoLEP as an enucleation technique replace M-TURP. Healthcare services and government spending should be organized according to these data. Cite this article as: _Ibis MA, Cayan S, Tokatli Z, et al. Trends in benign prostatic hyperplasia surgery over the years: A multicenter 14-year retrospective study. Turk J Urol. 2021; 47(6): 501-508
- 26 November 2021
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 47 (6) , 501-508
Open AccessTrends in benign prostatic hyperplasia surgery over the years: A multicenter 14-year retrospective study
Objective: The aim of this study is to show the surgical trend over the past 14 years using the data from five major centers in Turkey with accumulated experience in benign prostatic hyperplasia (BPH) surgery. Material and methods: This study included 94,954 patients with low urinary tract symptoms (LUTSs) secondary to BPH. By using electronic databases, we identified 7,163 patients who underwent BPH surgery, including monopolar transurethral prostate resection (M-TURP), bipolar transurethral prostate resection (BTURP), transurethral incision of the prostate (TUIP), open prostatectomy (OP), and holmium laser enucleation of the prostate (HoLEP) from 2006 to 2019. The years were grouped as 2006-2010, 2011-2015, and 2016-2019. Results: The total number of outpatient treatments for BPH increased by 72.9% from 5,379 in 2006 to 9,302 in 2019. Until 2019, the annual number of surgeries increased from 375 to 937 (increasing 150%). All surgical approaches for BPH, except TUIP, were most frequently performed between the ages of 60 and 69. The rate of surgery including M-TURP, B-TURP, and TUIP was statistically different between 2006 and 2010, 2011 and 2015, and 2016 and 2019 (P < .001), except OP (P ¼ .071). The highest increase was observed in HoLEP in the first half of the 2010s compared to the second half of the 2010s. The rate of M-TURP decreased from 77.9% to 17.9% from 2016 to 2019. Conclusion: With the aging population, the number of patients diagnosed and treated with BPH is increasing. B-TURP as a resection technique and HoLEP as an enucleation technique replace M-TURP. Healthcare services and government spending should be organized according to these data. Cite this article as: _Ibis MA, Cayan S, Tokatli Z, et al. Trends in benign prostatic hyperplasia surgery over the years: A multicenter 14-year retrospective study. Turk J Urol. 2021; 47(6): 501-508
- Open Access
- 1 January 2021
- Published by Turkiye Klinikleri in Journal of Reconstructive Urology
- Vol. 11 (1) , 29-35
Results of 100 Units of Botulinum Toxin Administration in Overactive Bladder Treatment
Objective: This study aimed to analyze the efficiency and safety of botulinum toxin in patients who presented to urology clinic with overactive bladder (OAB). Material and Methods: Between 2015 and 2019, forty patients who were administered intravesical 100 units of botulinum toxin for OAB treatment were evaluated retrospectively in terms of efficacy and safety. Efficacy was evaluated by using the treatment benefit scale (TBS) at 3 months after injection The quality of life for OAB symptoms was evaluated via the incontinence quality of life scale before treatment and at the 3rd month after treatment. Likewise, parameters such as incontinence, nocturia, urinary frequency, post-void residual urine values, maximum urine flow rate, number of pads used were evaluated before and at the 3rd month after the procedure. Results: Significant increases were detected in post-procedure incontinence quality of life scores compared to pre-procedure, and in parallel with these results, significant increases were recorded in the post-treatment questionnaire (38.5±15.0 and 69.9±6.3, respectively); p<0.001). In addition, according to the TBS results at the 3rd month, 80% of the patients who underwent the procedure did benefit from the treatment. Conclusion: Botulinum toxin injection still remains to be an effective option in refractory OAB treatment.
- 1 January 2021
- Published by Turkiye Klinikleri in Journal of Reconstructive Urology
- Vol. 11 (1) , 29-35
Open AccessResults of 100 Units of Botulinum Toxin Administration in Overactive Bladder Treatment
Objective: This study aimed to analyze the efficiency and safety of botulinum toxin in patients who presented to urology clinic with overactive bladder (OAB). Material and Methods: Between 2015 and 2019, forty patients who were administered intravesical 100 units of botulinum toxin for OAB treatment were evaluated retrospectively in terms of efficacy and safety. Efficacy was evaluated by using the treatment benefit scale (TBS) at 3 months after injection The quality of life for OAB symptoms was evaluated via the incontinence quality of life scale before treatment and at the 3rd month after treatment. Likewise, parameters such as incontinence, nocturia, urinary frequency, post-void residual urine values, maximum urine flow rate, number of pads used were evaluated before and at the 3rd month after the procedure. Results: Significant increases were detected in post-procedure incontinence quality of life scores compared to pre-procedure, and in parallel with these results, significant increases were recorded in the post-treatment questionnaire (38.5±15.0 and 69.9±6.3, respectively); p<0.001). In addition, according to the TBS results at the 3rd month, 80% of the patients who underwent the procedure did benefit from the treatment. Conclusion: Botulinum toxin injection still remains to be an effective option in refractory OAB treatment.
- 1 October 2019
- Published by Wiley in Andrologia
- Vol. 51 (11) , e13430
Are predictive factors in sperm retrieval and pregnancy rates present in nonobstructive azoospermia patients by microdissection testicular sperm extraction on testicle with a history of orchidopexy operation?
The aim in this study is to evaluate predictive factors on sperm retrieval and pregnancy rates by microdissection testicular sperm extraction in non obstructive azoospermia patients with a history of orchidopexy operation. A total of 148 patients were included, and their medical files were evaluated. Data related to possible predictive factors on sperm retrieval and pregnancy rates such as age at orchidopexy operation, unilateral or bilateral presence of undescended testis before orchidopexy, testis volumes and hormone levels were statistically analysed. It revealed that the mean ages in patients with unilateral and bilateral orchidopexy operations were 35.37 (±4.84) and 33.94 (±5.91) respectively. Mean testis volume in the unilateral orchidopexy group was 7.59 (±3.12) ml on the right testis and 7.37 (±2.86) ml on the left testis. Mean FSH levels were detected as 22.71 (±11.86) mIU/ml in the unilateral group and 28.19 (±12.40) mIU/ml in the bilateral group. In our study, we have shown that the age at which patients undergo orchidopexy and the unilateral or bilateral presence of cryptorchidism has no correlation with sperm retrieval and pregnancy rates.
- 1 October 2019
- Published by Wiley in Andrologia
- Vol. 51 (11) , e13430
Are predictive factors in sperm retrieval and pregnancy rates present in nonobstructive azoospermia patients by microdissection testicular sperm extraction on testicle with a history of orchidopexy operation?
The aim in this study is to evaluate predictive factors on sperm retrieval and pregnancy rates by microdissection testicular sperm extraction in non obstructive azoospermia patients with a history of orchidopexy operation. A total of 148 patients were included, and their medical files were evaluated. Data related to possible predictive factors on sperm retrieval and pregnancy rates such as age at orchidopexy operation, unilateral or bilateral presence of undescended testis before orchidopexy, testis volumes and hormone levels were statistically analysed. It revealed that the mean ages in patients with unilateral and bilateral orchidopexy operations were 35.37 (±4.84) and 33.94 (±5.91) respectively. Mean testis volume in the unilateral orchidopexy group was 7.59 (±3.12) ml on the right testis and 7.37 (±2.86) ml on the left testis. Mean FSH levels were detected as 22.71 (±11.86) mIU/ml in the unilateral group and 28.19 (±12.40) mIU/ml in the bilateral group. In our study, we have shown that the age at which patients undergo orchidopexy and the unilateral or bilateral presence of cryptorchidism has no correlation with sperm retrieval and pregnancy rates.
- Open Access
- 18 June 2019
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 49 (3) , 821-825
Retrograde intrarenal surgery technique without using fluoroscopy and access sheet in the treatment of kidney stones
In this study, we aimed to present our results on single-guidewire flexible ureteroscopy and retrograde intrarenal surgery without fluoroscopy and an access sheet, and to evaluate the efficacy and safety of this procedure retrospectively. Our routine technique can be described as the evaluation of the ureter using a semirigid ureterorenoscope (URS), leading in the guidewire through the semirigid URS, pulling the semirigid URS back, inserting the flexible URS with the aid of the guidewire, inserting the laser probe through the flexible URS, and performing laser lithotripsy. Our study included 400 male and 198 female patients with a mean age of 36.8 ± 16 (14–80) years. The mean stone size was 8.7 ± 4 (8–20) mm, and the mean operation time was 56 (32–106) min. Postoperative fever was observed in 24 (4%) of the patients, and 30 (5%) patients had hematuria as a minor complication. A stone-free status was observed in 466 (78%) patients, while 102 (17%) patients had clinically insignificant minor stone fragments and 30 patients had clinically significant stone residue. The retrograde intrarenal surgery procedure using only a guidewire without fluoroscopy and an access sheet in the treatment of kidney stones is technically safe and effective.
- 18 June 2019
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 49 (3) , 821-825
Open AccessRetrograde intrarenal surgery technique without using fluoroscopy and access sheet in the treatment of kidney stones
In this study, we aimed to present our results on single-guidewire flexible ureteroscopy and retrograde intrarenal surgery without fluoroscopy and an access sheet, and to evaluate the efficacy and safety of this procedure retrospectively. Our routine technique can be described as the evaluation of the ureter using a semirigid ureterorenoscope (URS), leading in the guidewire through the semirigid URS, pulling the semirigid URS back, inserting the flexible URS with the aid of the guidewire, inserting the laser probe through the flexible URS, and performing laser lithotripsy. Our study included 400 male and 198 female patients with a mean age of 36.8 ± 16 (14–80) years. The mean stone size was 8.7 ± 4 (8–20) mm, and the mean operation time was 56 (32–106) min. Postoperative fever was observed in 24 (4%) of the patients, and 30 (5%) patients had hematuria as a minor complication. A stone-free status was observed in 466 (78%) patients, while 102 (17%) patients had clinically insignificant minor stone fragments and 30 patients had clinically significant stone residue. The retrograde intrarenal surgery procedure using only a guidewire without fluoroscopy and an access sheet in the treatment of kidney stones is technically safe and effective.
- 11 October 2008
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 179 (3) , 443-445
Urethral erosion of a bone screw after internal urethrotomy: a rare complication after pelvic trauma
Although screw breakage or loosening are rarely encountered, they were reported to occur after instability of the internal fixation.
- 11 October 2008
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 179 (3) , 443-445
Urethral erosion of a bone screw after internal urethrotomy: a rare complication after pelvic trauma
Although screw breakage or loosening are rarely encountered, they were reported to occur after instability of the internal fixation.